(Q55456849)

11 July 2018

title

NMDAR-independent, cAMP-dependent antidepressant actions of ketamine. (English)

1 reference

11 July 2018

author name string

Nathan H Wray

1

1 reference

11 July 2018

Jeffrey M Schappi

2

1 reference

11 July 2018

Harinder Singh

3

1 reference

11 July 2018

Nicolas B Senese

4

1 reference

11 July 2018

Mark M Rasenick

5

1 reference

11 July 2018

language of work or name

English

0 references

publication date

12 June 2018

1 reference

11 July 2018

published in

Molecular Psychiatry

1 reference

11 July 2018

https://scigraph.springernature.com/pub.10.1038/s41380-018-0083-8

exact match

0 references

cites work

The epidemiology of depression across cultures

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Antidepressant effects of ketamine in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Antidepressant action: to the nucleus and beyond

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

CREB, neurogenesis and depression

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Adenylyl cyclase-cyclicAMP signaling in mood disorders: role of the crucial phosphorylating enzyme protein kinase A

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Treatment of C6 glioma cells and rats with antidepressant drugs increases the detergent extraction of G(s alpha) from plasma membrane

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Postmortem brain tissue of depressed suicides reveals increased Gs alpha localization in lipid raft domains where it is less likely to activate adenylyl cyclase.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Lateral diffusion of Gαs in the plasma membrane is decreased after chronic but not acute antidepressant treatment: role of lipid raft and non-raft membrane microdomains

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Lipid raft microdomains and neurotransmitter signalling

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Caveolin-1 and lipid microdomains regulate Gs trafficking and attenuate Gs/adenylyl cyclase signaling

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

In search of the mechanisms of ketamine’s antidepressant effects: How robust is the evidence behind the mTor activation hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Antidepressants Accumulate in Lipid Rafts Independent of Monoamine Transporters to Modulate Redistribution of the G Protein, Gαs

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

New DAG and cAMP Sensors Optimized for Live-Cell Assays in Automated Laboratories

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Rules of engagement for NMDA receptor subunits

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Neural plasticity to stress and antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Regulation of peptide-chain elongation in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Bi-phasic change in BDNF gene expression following antidepressant drug treatment

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Effects of a ketamine metabolite on synaptic NMDAR function.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

PKA-CREB-BDNF signaling regulated long lasting antidepressant activities of Yueju but not ketamine

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

An astroglial basis of major depressive disorder? An overview.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Disruption of lipid-raft localized Gαs/tubulin complexes by antidepressants: a unique feature of HDAC6 inhibitors, SSRI and tricyclic compounds.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Membrane-mediated effect on ion channels induced by the anesthetic drug ketamine

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

Trapping of Syntaxin1a in Presynaptic Nanoclusters by a Clinically Relevant General Anesthetic

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0083-8

7 January 2021

10.1038/S41380-018-0083-8

Identifiers

DOI

1 reference

11 July 2018

Dimensions Publication ID

1104545884

0 references

1 reference

11 July 2018